BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17892857)

  • 1. ACE activity affects myogenic differentiation via mTOR signaling.
    Mori S; Tokuyama K
    Biochem Biophys Res Commun; 2007 Nov; 363(3):597-602. PubMed ID: 17892857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in ACE activity affects myogenic differentiation in C2C12 cells.
    Mori S; Tokuyama K
    Biochem Biophys Res Commun; 2007 Feb; 353(2):369-75. PubMed ID: 17188239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy.
    Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
    FEBS J; 2006 Aug; 273(16):3709-21. PubMed ID: 16869890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of constitutive expression of porcine IGFBP-3 on proliferation and differentiation of L6 myogenic cells.
    Xi G; Kamanga-Sollo E; Hathaway MR; Dayton WR; White ME
    Domest Anim Endocrinol; 2006 Jul; 31(1):35-51. PubMed ID: 16233971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic inhibits myogenic differentiation and muscle regeneration.
    Yen YP; Tsai KS; Chen YW; Huang CF; Yang RS; Liu SH
    Environ Health Perspect; 2010 Jul; 118(7):949-56. PubMed ID: 20299303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
    Han B; Tong J; Zhu MJ; Ma C; Du M
    Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    GarcĂ­a-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity.
    Kishioka Y; Thomas M; Wakamatsu J; Hattori A; Sharma M; Kambadur R; Nishimura T
    J Cell Physiol; 2008 Jun; 215(3):856-67. PubMed ID: 18163379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
    Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
    Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLD regulates myoblast differentiation through the mTOR-IGF2 pathway.
    Yoon MS; Chen J
    J Cell Sci; 2008 Feb; 121(Pt 3):282-9. PubMed ID: 18198186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S; Franchi G; Teng M; Leontiou CA; Ribeiro de Oliveira A; Dalino P; Salahuddin N; Korbonits M; Grossman AB
    Neuroendocrinology; 2008; 87(3):168-81. PubMed ID: 18025810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic effects of leucine and glutamine on the mTOR pathway in myogenic C2C12 cells.
    Deldicque L; Sanchez Canedo C; Horman S; De Potter I; Bertrand L; Hue L; Francaux M
    Amino Acids; 2008 Jun; 35(1):147-55. PubMed ID: 17978888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
    Kohlstedt K; Kellner R; Busse R; Fleming I
    Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained baculovirus-mediated expression in myogenic cells.
    Shen HC; Yeh CN; Chen GY; Huang SF; Chen CY; Chiu YC; Hu YC
    J Gene Med; 2008 Nov; 10(11):1190-7. PubMed ID: 18729240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways.
    Deldicque L; Theisen D; Bertrand L; Hespel P; Hue L; Francaux M
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1263-71. PubMed ID: 17652429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The collagen derived dipeptide hydroxyprolyl-glycine promotes C2C12 myoblast differentiation and myotube hypertrophy.
    Kitakaze T; Sakamoto T; Kitano T; Inoue N; Sugihara F; Harada N; Yamaji R
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1292-7. PubMed ID: 27553280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes.
    Ko JA; Kimura Y; Matsuura K; Yamamoto H; Gondo T; Inui M
    J Cell Sci; 2006 Dec; 119(Pt 24):5106-13. PubMed ID: 17118964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.